Vistagen Therapeutics Statistics
Total Valuation
VTGN has a market cap or net worth of $24.73 million. The enterprise value is -$35.24 million.
Important Dates
The next estimated earnings date is Tuesday, June 16, 2026, after market close.
| Earnings Date | Jun 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VTGN has 39.62 million shares outstanding. The number of shares has increased by 15.56% in one year.
| Current Share Class | 39.62M |
| Shares Outstanding | 39.62M |
| Shares Change (YoY) | +15.56% |
| Shares Change (QoQ) | +18.14% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 29.75% |
| Float | 34.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 31.82 |
| Forward PS | 24.01 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.67 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -101.55% and return on invested capital (ROIC) is -64.64%.
| Return on Equity (ROE) | -101.55% |
| Return on Assets (ROA) | -55.53% |
| Return on Invested Capital (ROIC) | -64.64% |
| Return on Capital Employed (ROCE) | -135.66% |
| Weighted Average Cost of Capital (WACC) | 5.59% |
| Revenue Per Employee | $13,373 |
| Profits Per Employee | -$1.14M |
| Employee Count | 59 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.10% in the last 52 weeks. The beta is 0.30, so VTGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -74.10% |
| 50-Day Moving Average | 0.60 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 50.62 |
| Average Volume (20 Days) | 828,675 |
Short Selling Information
The latest short interest is 1.76 million, so 4.44% of the outstanding shares have been sold short.
| Short Interest | 1.76M |
| Short Previous Month | 1.71M |
| Short % of Shares Out | 4.44% |
| Short % of Float | 5.11% |
| Short Ratio (days to cover) | 2.03 |
Income Statement
In the last 12 months, VTGN had revenue of $789,000 and -$67.05 million in losses. Loss per share was -$1.89.
| Revenue | 789,000 |
| Gross Profit | 789,000 |
| Operating Income | -69.90M |
| Pretax Income | -67.05M |
| Net Income | -67.05M |
| EBITDA | -69.72M |
| EBIT | -69.90M |
| Loss Per Share | -$1.89 |
Full Income StatementBalance Sheet
The company has $61.77 million in cash and $1.43 million in debt, with a net cash position of $60.34 million or $1.52 per share.
| Cash & Cash Equivalents | 61.77M |
| Total Debt | 1.43M |
| Net Cash | 60.34M |
| Net Cash Per Share | $1.52 |
| Equity (Book Value) | 50.92M |
| Book Value Per Share | 1.29 |
| Working Capital | 49.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$60.30 million and capital expenditures -$239,000, giving a free cash flow of -$60.54 million.
| Operating Cash Flow | -60.30M |
| Capital Expenditures | -239,000 |
| Depreciation & Amortization | 187,000 |
| Net Borrowing | 378,000 |
| Free Cash Flow | -60.54M |
| FCF Per Share | -$1.53 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -8,859.82% |
| Pretax Margin | -8,497.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VTGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.56% |
| Shareholder Yield | -15.56% |
| Earnings Yield | -267.04% |
| FCF Yield | -241.11% |
Analyst Forecast
The average price target for VTGN is $0.97, which is 55.42% higher than the current price. The consensus rating is "Hold".
| Price Target | $0.97 |
| Price Target Difference | 55.42% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 167.81% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
VTGN has an Altman Z-Score of -8.68 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.68 |
| Piotroski F-Score | 2 |
